ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
렘데시비르 시장 규모는 최근 급격하게 확대되고 있습니다. 2025년 85억 2,000만 달러에서 2026년에는 111억 7,000만 달러에 이르고, CAGR 31.2%의 성장이 전망되고 있습니다. 지금까지의 성장은 렘데시비르의 긴급 사용 허가, 코로나19 피크 시기의 높은 입원율, 제한된 항바이러스 치료 옵션, 항바이러스 요법에 대한 인식 개선, 병원 조달 채널의 급속한 확대 등이 주요 요인으로 꼽힙니다.
렘데시비르 시장 규모는 향후 몇 년간 급성장이 전망됩니다. 2030년에는 179억 6,000만 달러에 이르고, CAGR은 12.6%를 나타낼 전망입니다. 예측 기간의 성장 요인으로는 신규 렘데시비르 제제 개발, 경구제 및 즉시 사용 가능한 주사제 채택 확대, 원격 의료 지원형 항바이러스 투여 확대, 코로나19 관리를 위한 정부 정책 강화, 온라인 약국 및 택배 서비스 성장 등을 꼽을 수 있습니다. 예측 기간 동안 주요 동향으로는 정맥 내 항바이러스 요법에 대한 수요 증가, 경구용 항바이러스 제제의 채택 확대, 코로나19에 대한 입원 치료 및 집중 치료 증가, 온라인 및 소매 약국 유통 채널 확대, 즉시 사용 가능한 주사제 및 동결건조 분말 제제 개발 등을 들 수 있습니다.
정부 지출 증가는 향후 몇 년 동안 렘데시비르 시장의 성장을 뒷받침할 것으로 예측됩니다. 정부 지출(정부 지출이라고도 함)은 정부 또는 공공 부문 기관이 운영, 프로그램, 서비스, 개발 이니셔티브에 자금을 제공하기 위해 할당하고 지출하는 총 자금을 의미합니다. 정부 지출은 특히 공중보건 비상사태에서 렘데시비르의 가용성과 접근성을 높이는 데 중요한 역할을 합니다. 정부는 재정 지원, 규제 완화, 일괄 조달, 연구 투자를 통해 이 필수 항바이러스제의 가격과 공급을 보장하는 데 도움을 줄 것입니다. 예를 들어, 미국 의사협회(미국 소재 전문기관)에 따르면, 2025년 4월 기준 미국의 의료비 지출은 2023년 7.5% 증가하여 4조 9,000억 달러(1인당 1만 4,570달러)에 달하고, 2022년 4.6% 증가를 넘어설 것으로 예상했습니다. 그 결과, 정부 지출 증가가 렘데시비르 시장의 성장에 기여하고 있습니다.
헬스케어 지출 증가는 앞으로도 렘데시비르 시장의 성장을 견인할 것으로 예측됩니다. 헬스케어 지출은 개인, 기관 또는 정부가 건강 상태의 예방, 치료, 관리를 위해 지출하는 총 자금을 의미합니다. 헬스케어 기술의 발전과 함께 혁신적인 진단 도구, 치료법, 요법은 종종 고비용을 수반하기 때문에 헬스케어 지출은 계속 증가하고 있으며, 그 결과 전체 헬스케어 예산이 확대되고 있습니다. 의료비 지출 증가는 정부와 의료 기관이 충분한 공급을 보장하고, 유통 시스템을 강화하며, 코로나19 환자에게 적시에 치료를 제공할 수 있게 함으로써 환자의 접근성과 임상 결과를 개선할 수 있습니다. 이를 통해 환자의 접근성과 임상 결과를 개선할 수 있습니다. 예를 들어, 미국의 메디케어 및 메디케이드 프로그램을 감독하는 기관인 메디케어-메디케이드 서비스 센터(CMS)에 따르면, 2024년 12월 기준 2023년 미국의 의료비 지출은 7.5% 증가하여 4조 9,000억 달러(약 1,4,570달러/인당)에 달할 것으로 예상하고 있습니다. 명)에 도달했습니다. 그 결과, 의료비 지출 증가는 렘데시비르 시장의 성장을 가속하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의의 공급망에 대한 영향, 코로나 팬데믹이 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 TAM(Total Addressable Market) 규모
제9장 시장 세분화
제10장 지역별/국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업 및 혁신 기업
제38장 세계 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병(M&A)
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
LSH
영문 목차
영문목차
Remdesivir is an antiviral medication used to treat hospitalized adults and children aged 28 days and older who weigh at least 6.6 pounds (3 kg) for coronavirus disease 2019 (COVID-19), which is caused by the SARS-CoV-2 virus. It is administered to patients who are at high risk of progressing to severe COVID-19, a condition that may lead to hospitalization or death.
The primary routes of administration for remdesivir are oral and intravenous. Intravenous administration refers to the delivery of a drug or other substance directly into a vein through a syringe or tubing. The various dosage forms include tablets, frozen solutions, and lyophilized solutions, and these are distributed through multiple channels such as hospitals, clinics, drug stores or pharmacies, online platforms, and others.
Tariffs have impacted the remdesivir market by increasing costs of imported active pharmaceutical ingredients, excipients, and packaging materials, affecting production and distribution. Intravenous formulations and lyophilized powders are most impacted, particularly in regions like North America and Europe that rely heavily on imports. While tariffs have raised treatment costs and slowed supply chains, they have also promoted local manufacturing, innovation in formulation technologies, and increased self-reliance in domestic production capacities.
The remdesivir market research report is one of a series of new reports from The Business Research Company that provides remdesivir market statistics, including remdesivir industry global market size, regional shares, competitors with a remdesivir market share, detailed remdesivir market segments, market trends and opportunities, and any further data you may need to thrive in the remdesivir industry. This remdesivir market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The remdesivir market size has grown exponentially in recent years. It will grow from $8.52 billion in 2025 to $11.17 billion in 2026 at a compound annual growth rate (CAGR) of 31.2%. The growth in the historic period can be attributed to emergency use authorization of remdesivir, high hospitalization rates during covid-19 peaks, limited antiviral treatment options, growing awareness of antiviral therapies, rapid scale-up of hospital procurement channels.
The remdesivir market size is expected to see rapid growth in the next few years. It will grow to $17.96 billion in 2030 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to development of novel remdesivir formulations, increasing adoption of oral and ready-to-use injectable solutions, expansion of telemedicine-supported antiviral administration, rising government initiatives for covid-19 management, growth in online pharmacy and home delivery services. Major trends in the forecast period include rising demand for intravenous antiviral therapies, increased adoption of oral antiviral formulations, growth in hospitalization and critical care treatments for covid-19, expansion of online and retail pharmacy distribution channels, development of ready-to-use injectable and lyophilized powder solutions.
The growth in government expenditure is expected to support the expansion of the remdesivir market in the coming years. Government expenditure, also referred to as government spending, represents the total funds allocated and spent by governments or public sector bodies to finance operations, programs, services, and development initiatives. Government spending plays a key role in enhancing the availability and accessibility of remdesivir, particularly during public health emergencies. Through financial support, regulatory facilitation, bulk procurement, and investments in research, governments help ensure the affordability and supply of this essential antiviral drug. For example, in April 2025, according to the American Medical Association, a US-based professional organization, U.S. health spending increased by 7.5% in 2023, reaching $4.9 trillion, or $14,570 per capita, surpassing the 4.6% growth recorded in 2022. As a result, rising government expenditure is contributing to the growth of the remdesivir market.
The increase in healthcare expenditure is also expected to drive the growth of the remdesivir market going forward. Healthcare expenditure refers to the total financial resources spent by individuals, institutions, or governments on the prevention, treatment, and management of health conditions. Healthcare spending continues to rise due to advancements in medical technologies, as innovative diagnostic tools, treatments, and therapies often involve higher costs, leading to increased overall healthcare budgets. Higher healthcare expenditure supports the adoption of remdesivir by enabling governments and healthcare facilities to secure adequate supplies, strengthen distribution systems, and provide timely treatment for COVID-19 patients, thereby improving patient access and clinical outcomes. For instance, in December 2024, according to the Centers for Medicare & Medicaid Services, a US-based agency overseeing Medicare and Medicaid programs, U.S. healthcare spending rose by 7.5% in 2023, reaching $4.9 trillion, or approximately $14,570 per person. Consequently, rising healthcare expenditure is fueling the growth of the remdesivir market.
The growing demand for clinical trials and research is further expected to propel the expansion of the remdesivir market. Clinical trials and research involve structured and systematic studies conducted in healthcare and medical sciences to assess the safety, effectiveness, and performance of drugs, treatments, medical devices, diagnostic tools, and healthcare interventions. Clinical trials play a critical role in evaluating the safety and efficacy of remdesivir in treating viral infections, including COVID-19. These studies generate scientific evidence supporting the drug's ability to reduce disease severity and duration while establishing its safety profile. For example, in May 2023, according to Xtalks, a Canada-based digital health company, a total of 452,604 clinical studies were registered globally in 2023, with 64,838 actively recruiting participants. Therefore, the increasing emphasis on clinical trials and research is driving the growth of the remdesivir market.
Major companies operating in the remdesivir market are Gilead Sciences Inc., BrightGene Bio-Medical Technology Co Ltd, Hainan Haiyao Co. Ltd., Sichuan Kelun Pharmaceutical Co. Ltd., Hunan Warrant Pharmaceutical, Cipla Limited, Dr Reddy's Laboratories Ltd., Shenzhen BORUI Pharmaceutical Technology Co. Ltd., Hetero Labs Limited, Mylan N.V., Zydus Cadila Health Care Limited, Syngene International Limited, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Teva Pharmaceutical Industries, Ferozsons Laboratories Limited, Jubilant Life Sciences, Laurus Labs, Macleods Pharmaceuticals, Natco Pharma, Sandoz Group AG, Strides Pharma Science Limited, Torrent Pharmaceuticals, Beximco Pharmaceuticals Ltd., Fresenius Kabi, Gland Pharma Limited, Hikma Pharmaceuticals, Lark Laboratories
North America was the largest region in the remdesivir market in 2025. Middle East is expected to be the fastest growing region in the remdesivir market report during the forecast period. The regions covered in the remdesivir market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the remdesivir market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The remdesivir market consists of sales of nucleotide analogue and Veklury. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Remdesivir Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses remdesivir market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for remdesivir ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The remdesivir market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Route Of Administration: Oral; Intravenous
2) By Dosage Form: Tablets; Frozen Solution; Lyophilized Solution
3) By Distribution Channel: Hospitals; Clinics; Drug Stores/Pharmacies; Online; Other Distribution Channels
Subsegments:
1) By Oral: Tablet Formulation; Liquid Formulation
2) By Intravenous: Ready-To-Use Injectable; Lyophilized Powder For Injection
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
4.2.1 Rising Demand For Intravenous Antiviral Therapies
4.2.2 Increased Adoption Of Oral Antiviral Formulations
4.2.3 Growth In Hospitalization And Critical Care Treatments For COVID-19
4.2.4 Expansion Of Online And Retail Pharmacy Distribution Channels
4.2.5 Development Of Ready-To-Use Injectable And Lyophilized Powder Solutions
5. Remdesivir Market Analysis Of End Use Industries
5.1 Hospitals
5.2 Clinics
5.3 Drug Stores/Pharmacies
5.4 Online Pharmacies
5.5 Home Care Providers
6. Remdesivir Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Remdesivir Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Remdesivir PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Remdesivir Market Size, Comparisons And Growth Rate Analysis
7.3. Global Remdesivir Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Remdesivir Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Remdesivir Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Remdesivir Market Segmentation
9.1. Global Remdesivir Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Oral, Intravenous
9.2. Global Remdesivir Market, Segmentation By Dosage Form, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Tablets, Frozen Solution, Lyophilized Solution
9.3. Global Remdesivir Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals, Clinics, Drug Stores/Pharmacies, Online, Other Distribution Channels
9.4. Global Remdesivir Market, Sub-Segmentation Of Oral, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Tablet Formulation, Liquid Formulation
9.5. Global Remdesivir Market, Sub-Segmentation Of Intravenous, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Ready-To-Use Injectable, Lyophilized Powder For Injection
10. Remdesivir Market Regional And Country Analysis
10.1. Global Remdesivir Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Remdesivir Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Remdesivir Market
11.1. Asia-Pacific Remdesivir Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Remdesivir Market, Segmentation By Route Of Administration, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Remdesivir Market
12.1. China Remdesivir Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Remdesivir Market, Segmentation By Route Of Administration, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Remdesivir Market
13.1. India Remdesivir Market, Segmentation By Route Of Administration, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Remdesivir Market
14.1. Japan Remdesivir Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Remdesivir Market, Segmentation By Route Of Administration, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Remdesivir Market
15.1. Australia Remdesivir Market, Segmentation By Route Of Administration, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Remdesivir Market
16.1. Indonesia Remdesivir Market, Segmentation By Route Of Administration, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Remdesivir Market
17.1. South Korea Remdesivir Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Remdesivir Market, Segmentation By Route Of Administration, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Remdesivir Market
18.1. Taiwan Remdesivir Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Remdesivir Market, Segmentation By Route Of Administration, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Remdesivir Market
19.1. South East Asia Remdesivir Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Remdesivir Market, Segmentation By Route Of Administration, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Remdesivir Market
20.1. Western Europe Remdesivir Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Remdesivir Market, Segmentation By Route Of Administration, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Remdesivir Market
21.1. UK Remdesivir Market, Segmentation By Route Of Administration, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Remdesivir Market
22.1. Germany Remdesivir Market, Segmentation By Route Of Administration, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Remdesivir Market
23.1. France Remdesivir Market, Segmentation By Route Of Administration, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Remdesivir Market
24.1. Italy Remdesivir Market, Segmentation By Route Of Administration, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Remdesivir Market
25.1. Spain Remdesivir Market, Segmentation By Route Of Administration, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Remdesivir Market
26.1. Eastern Europe Remdesivir Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Remdesivir Market, Segmentation By Route Of Administration, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Remdesivir Market
27.1. Russia Remdesivir Market, Segmentation By Route Of Administration, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Remdesivir Market
28.1. North America Remdesivir Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Remdesivir Market, Segmentation By Route Of Administration, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Remdesivir Market
29.1. USA Remdesivir Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Remdesivir Market, Segmentation By Route Of Administration, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Remdesivir Market
30.1. Canada Remdesivir Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Remdesivir Market, Segmentation By Route Of Administration, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Remdesivir Market
31.1. South America Remdesivir Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Remdesivir Market, Segmentation By Route Of Administration, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Remdesivir Market
32.1. Brazil Remdesivir Market, Segmentation By Route Of Administration, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Remdesivir Market
33.1. Middle East Remdesivir Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Remdesivir Market, Segmentation By Route Of Administration, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Remdesivir Market
34.1. Africa Remdesivir Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Remdesivir Market, Segmentation By Route Of Administration, Segmentation By Dosage Form, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Remdesivir Market Regulatory and Investment Landscape
36. Remdesivir Market Competitive Landscape And Company Profiles
36.1. Remdesivir Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Remdesivir Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Remdesivir Market Company Profiles
36.3.1. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.2. BrightGene Bio-Medical Technology Co Ltd Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Hainan Haiyao Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Sichuan Kelun Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Hunan Warrant Pharmaceutical Overview, Products and Services, Strategy and Financial Analysis
37. Remdesivir Market Other Major And Innovative Companies
Cipla Limited, Dr Reddy's Laboratories Ltd., Shenzhen BORUI Pharmaceutical Technology Co. Ltd., Hetero Labs Limited, Mylan N.V., Zydus Cadila Health Care Limited, Syngene International Limited, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Teva Pharmaceutical Industries, Ferozsons Laboratories Limited, Jubilant Life Sciences, Laurus Labs, Macleods Pharmaceuticals, Natco Pharma
38. Global Remdesivir Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Remdesivir Market
40. Remdesivir Market High Potential Countries, Segments and Strategies
40.1 Remdesivir Market In 2030 - Countries Offering Most New Opportunities
40.2 Remdesivir Market In 2030 - Segments Offering Most New Opportunities
40.3 Remdesivir Market In 2030 - Growth Strategies
